搜索临床试验以:TORC1/2 inhibitor
总计103697个结果
-
Kathy MillerMillennium Pharmaceuticals, Inc.; Big Ten Cancer Research Consortium终止
-
Millennium Pharmaceuticals, Inc.完全的
-
National Cancer Institute (NCI)主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢透明细胞囊腺癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性囊腺癌 | 子宫内膜透明细胞腺癌 | 子宫内膜浆液性腺癌 | 复发性子宫体癌 | IIIA 期输卵管癌 AJCC v7 | IIIA 期卵巢癌 AJCC v6 和 v7 | IIIA 期原发性腹膜癌 AJCC v7 | IIIB 期输卵管癌 AJCC v7 | IIIB 期卵巢癌 AJCC v6 和 v7 | IIIB 期原发性腹膜癌 AJCC v7 | IIIC 期输卵管癌 AJCC v7 | IIIC 期卵巢癌 AJCC v6 和 v7 | IIIC 期原发性腹膜癌 AJCC v7 | IV 期输卵管癌 AJCC v6 和 v7 | IV 期卵巢癌 AJCC v6... 及其他条件美国
-
Paloma Pharmaceuticals, Inc.完全的
-
Antengene Therapeutics Limited终止
-
Xuanwu Hospital, BeijingPeking University People's Hospital; Chinese PLA General Hospital未知
-
Gazi UniversityHacettepe University; Cukurova University; Marmara University; Istanbul University; TC Erciyes University 和其他合作者未知
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的
-
Jin-Hee AhnAsan Medical Center未知HER-2基因扩增 | HER-2 蛋白过表达
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的
-
University of BirminghamUniversity College, London; National Institute for Health Research, United Kingdom招聘中
-
Changzhou No.2 People's Hospital未知
-
Pathalys PharmaLaunch Therapeutics招聘中
-
Chinese PLA General Hospital未知